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TAM receptors promote apoptotic cell uptake and function as inflammation suppressors. Many viruses
mimic apoptotic cells, thus exploiting TAM receptors for attachment and entry. In this issue of Cell Host &
Microbe, Bhattacharyya et al. show that TAM binding by enveloped viruses also induces receptor signaling
to suppress cellular interferon responses.Viral RNA recognition initiates signal
transduction cascades that trigger the
production of type I interferon (IFN) and
inflammatory cytokines very rapidly after
infection. This results in the generation of
an inhospitable cellular environment for
virus replication and the recruitment of
the cellular cavalry for initiating and
shaping adaptive immunity. Accordingly,
all successful pathogenic viruses have
evolved mechanisms to subvert this early
host response. However, many virus-
encoded strategies require new virus
replication for the viral antagonist to be ex-
pressed. Therefore, virusesmust generate
the very ligands that trigger type I IFN and
IFN-stimulated gene expression before
their antagonism can be implemented.
The Tyro3/Axl/Mer (TAM) family of re-
ceptor tyrosine kinases (RTKs) (Lai and
Lemke, 1991) function in two critical roles,
both involving their natural ligands,Protein
S and Gas6 (Lemke and Rothlin, 2008).
The first is the uptake of apoptotic cells.
In healthy cells, phosphatidylserine
(PtdSer) is maintained at the inner leaflet
of the plasma membrane. In cells under-
going death by apoptosis, PtdSer is
exposed on the cell surface, where it is
accessible to binding by Protein S or
Gas6. Then, TAM binding to Protein S or
Gas6 tethers the apoptotic cell for subse-
quent phagocytosis. This function of TAM
receptors is cooptedby viruses that derive
an envelope from host cells. As originally
shown for vaccinia virus (Mercer and Hel-
enius, 2008), enveloped viruses display
PtdSer in an act of ‘‘apoptotic mimicry’’
to enhance virus attachment and entry
via a Protein S or Gas6 bridge to TAM-
expressing cells (Jemielity et al., 2013;
Morizono et al., 2011) (Figure 1). The
importance of this mechanism for the
replication of diverse viruses, includingpox-, retro-, flavi-, arena-, filo-, and
alpha-viruses, has been demonstrated.
The second function of TAM receptors
is as negative regulators of pathogen
recognition and type I IFN signaling path-
ways (Lu and Lemke, 2001; Rothlin et al.,
2007). After binding to Protein S or Gas6,
TAM RTK activation results in the upregu-
lation of potent negative regulators of
signaling, including suppressor of cyto-
kine signaling protein 1 (SOCS1) and
SOCS3 (Rothlin et al., 2007). SOCS1 and
SOCS3 negatively regulate Janus kinase
activity and thereby broadly inhibit IFN-
and cytokine-dependent signaling (Li-
nossi et al., 2013). SOCS proteins also
suppress Toll-like receptor (TLR)-medi-
ated activation of p38 MAP kinase,
nuclear factor kB (NF-kB), tumor-necro-
sis-associated factor 3 (TRAF3), and
TRAF6, resulting in suppressed cytokine
expression (Rothlin et al., 2007). Many of
these signaling intermediates (e.g., NF-
kB) are common to both TLR and RIG-I-
like helicase (RLR) pathways, suggesting
that TAM RTK activation may act univer-
sally to temper antipathogen inflamma-
tory responses.
In this issue of Cell Host & Microbe,
Bhattacharyya et al. (2013) demonstrate
that enveloped viruses use their cloak of
PtdSer for more than entry; this cloak
also engages Protein S and induces
signaling by TAM receptors. This results
in a generalized suppression of type I
IFN signaling that promotes virus replica-
tion (Figure 1). First, the authors showed
that the stable expression of TAM recep-
tors enhanced the permissiveness of cells
to an HIV vector engineered to express
glycoproteins from different enveloped
viruses. Then, they performed the
converse experiment to show that bone-
marrow-derived dendritic cells (BMDCs)Cell Host & Microbe 14from mice deficient in each of the individ-
ual TAMs or deleted for all three (triple
knockout or TKO) were less susceptible
to infection than their wild-type (WT)
counterparts. However, the authors found
that the delivery of an HIV core protein to
the cytosol was similar in TAM-deficient
and WT BMDCs, suggesting that TAM re-
ceptors may regulate postentry events in
virus replication.
To examine this further, the authors
provided three key lines of evidence that
uncoupled the role of TAM receptors in vi-
rus entry from the ability of the receptors
to signal and negatively regulate innate
immunity. First, the expression of a
kinase-dead mutant of Axl in human em-
bryonic kidney 293T cells facilitated entry
of West Nile virus (WNV) similarly to the
expression of the WT receptor but
resulted in markedly decreased virus
replication over 24 hr. This suggested an
additional role for TAM receptors beyond
viral entry that required receptor activa-
tion and raised the possibility that the sup-
pression of innate immunity may be
involved. Second, in TKO BMDCs, treat-
ment with an antibody to neutralize type
I IFN restored WNV replication to levels
observed in WT DCs. Thus, the mecha-
nism of TAM augmentation was associ-
ated with the suppression of type I IFN
signaling and was not due to an intrinsic
block in virus replication. Third, the use
of a pharmacological inhibitor of TAM
RTK activity inhibited WNV replication in
WT BMDCs but not in TAM-deficient or
type I IFN receptor (IFNAR)-deficient
DCs. This set of experiments provided ge-
netic evidence that TAM RTK activation
augments virus replication by modulating
the type I IFN response.
This last experiment using a TAM RTK
inhibitor also suggests that the effects of, August 14, 2013 ª2013 Elsevier Inc. 117
Figure 1. TAMReceptors Promote Virus Replication by Two Distinct
Mechanisms
Enveloped viruses display phosphatidylserine to engage the TAM receptor
ligands and Protein S or Gas6 and bind TAM receptors to facilitate virus attach-
ment to a cell and entry. Virus ligation of TAM receptors also promotes receptor
activation, which, through cooperation with the type I IFN receptor (IFNAR), in-
ducesSOCS1andSOCS3expression. SOCS1andSOCS3are important nega-
tive regulators of IFN and cytokine signaling. In particular, SOCSupregulation in
DCs resulted in the decreased expression of genes associated with type I IFN
production, including IRF5, IRF7, IFNb, and IFNa4, thereby blunting the innate
antiviral response and promoting virus replication (Bhattacharyya et al. 2013).
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dependent on the presence
of IFNAR. This is consistent
with previous findings that
TAM receptors interact with
and usurp IFNAR (specifically
shown for IFNAR1 and Axl).
This switches the type I IFN
receptor from a generally
positive regulator of sig-
naling to a negative regulator
by coercing it to upregulate
the expression of SOCS1
and SOCS3. In fact, all nega-
tive regulation of TLR sig-
naling by TAM receptors
appears to be dependent on
IFNAR (Rothlin et al., 2007).
Thus, by engaging TAM
receptors, enveloped viruses
may be able to convert
IFNAR from a sworn enemy
to an ally. In so doing, antiviral
responses are suppressed
just as replication gets under-
way—an impressive feat for a
virus that is playing dead.
The importance of this
mechanism of immune sup-
pressionmay not be limited to
enveloped viruses. Drayman
et al. (2013) recently demon-
strated that viral glycopro-teins have evolved to structurally mimic
specific host ligands. In particular, they
showed that the glycoprotein of
SV40, a nonenveloped virus, structurally
mimics Gas6 and interacts with TAM re-
ceptors in order to facilitate virus repli-
cation. Augmentation of replication was
shown to occur at both virus entry and
a postentry step. Thus, both enveloped
and nonenveloped viruses may use
mechanistically linked strategies for qui-
eting inflammatory responses, although
this remains to be experimentally
verified.118 Cell Host & Microbe 14, August 14, 2013Other questions raised by the current
studies of Bhattacharyya et al. (2013)
include whether TAM-mediated sup-
pression extends to both TLR and RLR
signaling (Figure 1) and how long after
infection does it offer protection to the
virus from type I IFN. Regardless of
the answers to these questions, the
findings from Bhattacharyya et al.
(2013) have important implications,
given that they suggest that TAM RTK
antagonists may represent tangible
clinical opportunities for the treatment
of acute viral infection. By targeting aª2013 Elsevier Inc.host receptor, the inhibition
of TAM activation could shift
the balance in favor of the
patient by relieving TAM-
dependent suppression of
innate immunity.ACKNOWLEDGMENTS
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